Protocol Development and Quality Improvement

A7. The pharmacy workforce, in all

care settings, must have access to

complete patient medical records

and related health information.

A8. The pharmacy enterprise

should be integrated and modeled

to provide patient‑centered care

across the continuum (e.g., home

and outpatient infusion, specialty

pharmacy, community pharmacy,

acute care).

A9. The pharmacy workforce

should lead medication education

for patients and caregivers that

optimize outcomes, including in

care transitions.

A10. Pharmacists should play

an active role in ensuring that

ethical principles drive clinical

and business decisions related to

medication use.

A11. Health systems must provide

24/7 pharmacy services with

advanced clinical capability.

A12. Health systems should

support innovative models for

providing a safe and appropriate

level of pharmacy services for

small and rural hospitals or other

alternative practice settings.

A13. Pharmacy departments should

take responsibility for appropriate

medication use in the structuring

of external partnerships.

Patient-Centered

Care

D3. All newly hired

technicians should have

completed an ASHP/ACPE‑

accredited technician

education and training

program.

D4. Health systems should

require technicians to be

certified by the Pharmacy

Technician Certification

Board.

D5. Pharmacy departments

should foster the

development of professional

career paths for pharmacy

technicians.

Pharmacy Technician

Role, Education, &

Training

E3. Pharmacy must be an active and accountable

partner in the financial stewardship (e.g.,

minimizing waste, using cost‑effective therapies,

managing the supply chain) of care delivered in

all settings.

E4. Pharmacy practice leaders should ensure

evidence‑based medication use by continually

analyzing and reporting use patterns and

outcomes.

E5. Health systems should support

interprofessional innovation centers designed to

pursue breakthroughs in areas such as patient

experience, medication use, clinical outcomes,

operational efficiency, technology, and revenue

generation.

E6. Health systems should support the well‑being

and resiliency of their staffs.

E7. Pharmacy departments should strive to

achieve equity, diversity, and inclusion in all

technical, clinical, and leadership roles.

E8. The pharmacy enterprise should engage,

employ, or develop expertise in areas such as

finance, analytics, business management, quality

assurance, informatics, human resources, payer

relations, and supply chain management.

E9. Health systems should have a pharmacist

executive leader, with a reporting structure

consistent with other executive leaders, to

oversee and influence enterprise‑wide decision

making related to medication use and technology.

E10. The pharmacy workforce should assess and

mitigate risk in medication‑use systems across all

settings.

Leadership in

Medication Use &

Safety

B4. Health systems

should require

completion of ASHP‑

accredited residency

training as a minimum

credential for new

pharmacist practitioners.

B5. Pharmacists

should participate in

organization‑based

credentialing and

privileging processes

to ensure competency

within their scope of

practice.

B6. Pharmacy practice

leaders should ensure

that their workforce has

the necessary knowledge

and competency to

adapt to emerging

healthcare needs.

B7. Pharmacists

practicing in specialty

areas should be board‑

certified through the

Board of Pharmacy

Specialties or other

appropriate body.

Pharmacist Role,

Education, &

Training

C5. Virtual pharmacy

services (e.g.,

telepharmacy) should

be deployed to

optimize operational

and clinical services

that extend patient

care services and

enhance continuity of

care.

C6. The pharmacy

enterprise must have

sufficient resources to

develop, implement,

and maintain

technology‑related

medication‑use safety

standards.

C7. Pharmacy

departments should

have access to an

analytics resource,

such as a data scientist,

to collect, aggregate,

measure, visualize,

and disseminate

data related to the

financial and clinical

performance of

pharmacists.

C8. Pharmacy

departments should

use technology

to ensure the safe

compounding of sterile

products.

Technology

& Data Science

Used with permission from: American Society of Health-System Pharmacists (ASHP). PAI 2030 Recommendations. Available at https://www.ashp.org/Pharmacy-Practice/PAI/PAI-Recommendations.